Home524816 • BOM
add
Natco Pharma Ltd
Nakaraang pagsara
₹904.15
Sakop ng araw
₹873.00 - ₹909.60
Sakop ng taon
₹660.05 - ₹1,638.35
Market cap
156.83B INR
Average na Volume
91.90K
P/E ratio
9.23
Dividend yield
0.69%
Primary exchange
NSE
Mga balita tungkol sa merkado
CNBC
2 oras ang nakalipas
Stock futures tick higher following back-to-back winning weeks: Live updates
0.75%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.29B | -2.47% |
Gastos sa pagpapatakbo | 5.82B | 38.13% |
Net na kita | 4.81B | -28.09% |
Net profit margin | 36.17 | -26.27% |
Kita sa bawat share | 26.84 | -28.08% |
EBITDA | 5.72B | -29.13% |
Aktuwal na % ng binabayarang buwis | 16.02% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 24.97B | 35.02% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 76.12B | — |
Natitirang share | 179.10M | — |
Presyo para makapag-book | 2.13 | — |
Return on assets | — | — |
Return on capital | 16.26% | — |
Cash Flow
Net change in cash
| (INR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 4.81B | -28.09% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Itinatag
1981
Headquarters
Website
Mga Empleyado
4,016
